Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Controlled and Randomized Study Assessing the Effect of Dulaglutide add-on to Dietary Reinforcement Versus Dietary Reinforcement Alone in Patients With Type 2 Diabetes and Carriers of a Non-alcoholic Steatohepatitis

NCT03648554 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT03648554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03648554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Controlled and Randomized Study Assessing the Effect of Dulaglutide add-on to Dietary Reinforcement Versus Dietary Reinforcement Alone in Patients With Type 2 Diabetes and Carriers of a Non-alcoholic Steatohepatitis
Lead sponsor
Central Hospital, Nancy, France
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2019
Completion date
March 30, 2024
Enrollment
93 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, nash - nonalcoholic steatohepatitis